Ado-trastuzumab emtansine Intravenous and Esmolol Intravenous
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Esmolol Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: esmolol
Brand name: Brevibloc
Synonyms: Esmolol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Esomep-EZS
- Ado-trastuzumab emtansine Intravenous-Esomeprazole
- Ado-trastuzumab emtansine Intravenous-Esomeprazole and naproxen
- Ado-trastuzumab emtansine Intravenous-Esomeprazole Capsules
- Ado-trastuzumab emtansine Intravenous-Esomeprazole Delayed-Release Capsules
- Ado-trastuzumab emtansine Intravenous-Esomeprazole Delayed-Release Tablets
- Esmolol Intravenous-Adox Pak 2/100
- Esmolol Intravenous-Adoxa
- Esmolol Intravenous-Adoxa CK
- Esmolol Intravenous-Adoxa Pak
- Esmolol Intravenous-Adoxa Pak 1/100
- Esmolol Intravenous-Adoxa Pak 1/150